Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Matthew Brendon Might, Ph.D.

Concepts (147)

Back to Profile
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Matthew Might's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Matthew Might has written about over time.
Abnormalities, Multiple, 1 publications between 2014 and 2014, average publication date March 2014. DNA Mutational Analysis, 1 publications between 2016 and 2016, average publication date December 2016. Prenatal Diagnosis, 1 publications between 2016 and 2016, average publication date December 2016. Genetic Diseases, Inborn, 2 publications between 2016 and 2017, average publication date March 2017. Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase, 9 publications between 2014 and 2021, average publication date September 2018. High-Throughput Screening Assays, 2 publications between 2018 and 2021, average publication date September 2019. Congenital Disorders of Glycosylation, 4 publications between 2018 and 2021, average publication date November 2019. Induced Pluripotent Stem Cells, 5 publications between 2018 and 2021, average publication date February 2020. Computational Biology, 3 publications between 2020 and 2020, average publication date April 2020. Rare Diseases, 5 publications between 2015 and 2023, average publication date August 2020. General Practice, 1 publications between 2023 and 2023, average publication date March 2023. Nephrology, 1 publications between 2023 and 2023, average publication date March 2023.

To see the data from this visualization as text, click here.
Might's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (147)
Explore
_
Co-Authors (7)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.